A Phase IIb, Randomized, Double-blinded, Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis

Trial Profile

A Phase IIb, Randomized, Double-blinded, Clinical Trial of Autologous Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Oct 2017

At a glance

  • Drugs Mesenchymal stem cell therapy (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Cellular Biomedicine Group
  • Most Recent Events

    • 09 Feb 2017 Status changed from recruiting to completed.
    • 12 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Oct 2016.
    • 13 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Jul 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top